🔬 Science
14h ago
Long-term follow-up tracks benefits and risks of stem cell transplants for severe systemic sclerosis
Source ↗
👁 0
💬 0
An international study reports 60% progression-free survival at 10 years after autologous bone marrow transplantation, adding evidence of sustained positive clinical outcomes and long-term safety in patients treated for early severe systemic sclerosis.
Comments (0)